Interestingly, compared to benign and primary PC tissue, we also observed a rise in FAP expression in tissue samples from patients with neoadjuvant androgen deprivation therapy before radical prostatectomy, suggesting that neoadjuvant androgen deprivation therapy impacts the TME leading to increased FAP expression in some patients. The gene discussed is FAP; the disease is pachyonychia congenita.